Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3525LS1M
Performance in the last:
Follow this Portfolio
1D 0.0 %
1W -6.4 %
2W 3.1 %
1M 14.8 %
3M 12.3 %
6M 9.5 %
9M -28.4 %
1Y -16.2 %
Alpha
-36.0%
Beta
0.66
sharpe-R
-0.35
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.45
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-11-21 08:30:42
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -47.92%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 1 Month in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 25.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
PTCT PTC Therapeutics, Inc. Equity Buy 7% 6.71%
CDMO Avid Bioservices, Inc. Equity Buy 8.02% 17.95%
HCSG Healthcare Services Group, Inc. Equity Buy 6.91% 4.02%
NEOG Neogen Corporation Equity Buy 6.87% 3.91%
ATEC Alphatec Holdings, Inc. Equity Buy 8.06% 26.5%
CORT Corcept Therapeutics Incorporated Equity Buy 7.45% 12.05%
ITGR Integer Holdings Corporation Equity Buy 17.81% -2.48%
COLL Collegium Pharmaceutical, Inc. Equity Sell -3.07% 12.56%
VERU Veru Inc. Equity Sell -3.22% 25%
CUTR Cutera, Inc. Equity Sell -1.88% 46.43%
AMPH Amphastar Pharmaceuticals, Inc. Equity Sell -4.39% 4.34%
KIDS OrthoPediatrics Corp. Equity Sell -4.64% 0.86%
ENTA Enanta Pharmaceuticals, Inc. Equity Sell -3.84% 17.98%
The percentage of cash held in the portfolio is: 58.92%
** The description of each asset is available Here

The latest 5 Compositions change

2024-11-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7% 6.71%
CDMO Avid Bioservices, Inc. Buy 8.02% 17.95%
HCSG Healthcare Services Group, Inc. Buy 6.91% 4.02%
NEOG Neogen Corporation Buy 6.87% 3.91%
ATEC Alphatec Holdings, Inc. Buy 8.06% 26.5%
CORT Corcept Therapeutics Incorporated Buy 7.45% 12.05%
ITGR Integer Holdings Corporation Buy 17.81% -2.48%
COLL Collegium Pharmaceutical, Inc. Sell -3.07% 12.56%
VERU Veru Inc. Sell -3.22% 25%
CUTR Cutera, Inc. Sell -1.88% 46.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.39% 4.34%
KIDS OrthoPediatrics Corp. Sell -4.64% 0.86%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.84% 17.98%
The percentage of cash held in the portfolio is: 58.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Buy All 1.47%
IRTC Sell All -9.45%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.58% 0.1%
CDMO Avid Bioservices, Inc. Buy 8.02% 17.66%
HCSG Healthcare Services Group, Inc. Buy 6.9% 3.74%
NEOG Neogen Corporation Buy 6.98% 5.23%
ATEC Alphatec Holdings, Inc. Buy 7.79% 21.91%
CORT Corcept Therapeutics Incorporated Buy 7.23% 8.49%
IRTC iRhythm Technologies, Inc. Buy 6.09% -7.33%
ITGR Integer Holdings Corporation Buy 17.88% -2.37%
COLL Collegium Pharmaceutical, Inc. Sell -3.05% 13.29%
VERU Veru Inc. Sell -3.23% 25%
CUTR Cutera, Inc. Sell -1.88% 46.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.36% 5.36%
TNDM Tandem Diabetes Care, Inc. Sell -4.27% 8.92%
KIDS OrthoPediatrics Corp. Sell -4.43% 5.44%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.99% 14.91%
The percentage of cash held in the portfolio is: 57.74%
New Assets Added
None
Assets Removed
Asset Action Perf %
INCY Sell All -4.56%
MGNX Sell All -10.08%
MDRX Sell All -7.2%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.57% -0.23%
CDMO Avid Bioservices, Inc. Buy 7.99% 17.18%
HCSG Healthcare Services Group, Inc. Buy 7.02% 5.39%
NEOG Neogen Corporation Buy 6.76% 1.81%
INCY Incyte Corporation Buy 6.78% 2.62%
ATEC Alphatec Holdings, Inc. Buy 6.71% 4.84%
MGNX MacroGenics, Inc. Buy 6.16% -7.75%
CORT Corcept Therapeutics Incorporated Buy 6.91% 3.54%
IRTC iRhythm Technologies, Inc. Buy 6.5% -1.22%
ITGR Integer Holdings Corporation Buy 17.85% -2.62%
MDRX Allscripts Healthcare Solutions, Inc. Buy 7.63% -5.24%
COLL Collegium Pharmaceutical, Inc. Sell -3.03% 13.79%
VERU Veru Inc. Sell -2.98% 30.95%
CUTR Cutera, Inc. Sell -2.01% 42.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.46% 3.21%
TNDM Tandem Diabetes Care, Inc. Sell -4.19% 10.65%
KIDS OrthoPediatrics Corp. Sell -4.18% 10.85%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.04% 13.91%
The percentage of cash held in the portfolio is: 38.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
BHVN Buy All 13.76%
RGEN Sell All -17.11%
VREX Sell All 13.22%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 7.06% 12.89%
PTCT PTC Therapeutics, Inc. Buy 6.94% 7.78%
CDMO Avid Bioservices, Inc. Buy 7.69% 15.15%
HCSG Healthcare Services Group, Inc. Buy 7.1% 8.95%
NEOG Neogen Corporation Buy 6.63% 2.09%
INCY Incyte Corporation Buy 6.79% 5.14%
ATEC Alphatec Holdings, Inc. Buy 6.96% 11.21%
MGNX MacroGenics, Inc. Buy 6.43% -1.55%
CORT Corcept Therapeutics Incorporated Buy 7.15% 9.45%
IRTC iRhythm Technologies, Inc. Buy 6.59% 2.46%
ITGR Integer Holdings Corporation Buy 17.69% -1.41%
MDRX Allscripts Healthcare Solutions, Inc. Buy 7.57% -3.91%
RGEN Repligen Corporation Buy 5.83% -5.34%
BHVN Biohaven Ltd. Sell -3.18% 5.46%
COLL Collegium Pharmaceutical, Inc. Sell -3.04% 11.77%
VERU Veru Inc. Sell -3.17% 25%
CUTR Cutera, Inc. Sell -2.03% 41.07%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.41% 2.23%
TNDM Tandem Diabetes Care, Inc. Sell -4.29% 6.57%
KIDS OrthoPediatrics Corp. Sell -4.05% 11.78%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.2% 8.49%
The percentage of cash held in the portfolio is: 27.93%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All 26.23%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 6.97% 15.04%
PTCT PTC Therapeutics, Inc. Buy 6.99% 11.98%
NUTX Nutex Health Inc. Buy 8.23% 31.39%
CDMO Avid Bioservices, Inc. Buy 7.62% 17.76%
HCSG Healthcare Services Group, Inc. Buy 7.04% 11.32%
NEOG Neogen Corporation Buy 6.66% 5.86%
INCY Incyte Corporation Buy 6.82% 8.86%
ATEC Alphatec Holdings, Inc. Buy 7.06% 16.31%
MGNX MacroGenics, Inc. Buy 6.17% -2.58%
CORT Corcept Therapeutics Incorporated Buy 7.14% 12.76%
IRTC iRhythm Technologies, Inc. Buy 6.68% 6.99%
ITGR Integer Holdings Corporation Buy 17.49% 0.58%
MDRX Allscripts Healthcare Solutions, Inc. Buy 7.57% -0.89%
ALT Altimmune, Inc. Buy 5.89% 0.32%
RGEN Repligen Corporation Buy 5.97% 0%
BHVN Biohaven Ltd. Sell -3.1% 4.72%
COLL Collegium Pharmaceutical, Inc. Sell -2.94% 12.04%
VERU Veru Inc. Sell -3.02% 26.19%
CUTR Cutera, Inc. Sell -2.14% 35.71%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.32% 1.32%
TNDM Tandem Diabetes Care, Inc. Sell -4.32% 3.04%
KIDS OrthoPediatrics Corp. Sell -4.2% 5.68%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.2% 5.78%
The percentage of cash held in the portfolio is: 13.94%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
CARA Sell All -6.09%
ARWR Sell All 11.73%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.2% 11.11%
VREX Varex Imaging Corporation Buy 7.05% 18.26%
PTCT PTC Therapeutics, Inc. Buy 6.97% 13.48%
NUTX Nutex Health Inc. Buy 9.32% 51.33%
CDMO Avid Bioservices, Inc. Buy 7.51% 18.05%
HCSG Healthcare Services Group, Inc. Buy 7.06% 13.61%
NEOG Neogen Corporation Buy 6.62% 6.97%
INCY Incyte Corporation Buy 6.71% 8.99%
ATEC Alphatec Holdings, Inc. Buy 7.06% 18.22%
MGNX MacroGenics, Inc. Buy 6.6% 5.94%
CORT Corcept Therapeutics Incorporated Buy 7.19% 15.44%
IRTC iRhythm Technologies, Inc. Buy 6.57% 7.07%
CARA Cara Therapeutics, Inc. Buy 5.86% -1.16%
ITGR Integer Holdings Corporation Buy 17.12% 0.1%
MDRX Allscripts Healthcare Solutions, Inc. Buy 7.42% -1.24%
ALT Altimmune, Inc. Buy 5.77% 0%
BHVN Biohaven Ltd. Sell -3.13% 2.16%
COLL Collegium Pharmaceutical, Inc. Sell -3.01% 8.45%
VERU Veru Inc. Sell -3.16% 21.43%
CUTR Cutera, Inc. Sell -2.28% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.45% -3.51%
TNDM Tandem Diabetes Care, Inc. Sell -4.45% -1.63%
KIDS OrthoPediatrics Corp. Sell -4.09% 6.53%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.22% 3.7%
The percentage of cash held in the portfolio is: 7.77%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
IBRX Sell All 17.58%
IOVA Sell All -12.15%
Assets Rebalanced
None
2024-11-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.32% 13.48%
VREX Varex Imaging Corporation Buy 7.19% 20.74%
PTCT PTC Therapeutics, Inc. Buy 7% 14.11%
NUTX Nutex Health Inc. Buy 6.92% 12.45%
CDMO Avid Bioservices, Inc. Buy 7.51% 18.24%
IBRX ImmunityBio, Inc. Buy 6.77% 29.45%
HCSG Healthcare Services Group, Inc. Buy 6.92% 11.51%
IOVA Iovance Biotherapeutics, Inc. Buy 5.91% -3.45%
NEOG Neogen Corporation Buy 7.07% 14.37%
INCY Incyte Corporation Buy 6.78% 10.28%
ATEC Alphatec Holdings, Inc. Buy 7.36% 23.57%
MGNX MacroGenics, Inc. Buy 7.06% 13.44%
CORT Corcept Therapeutics Incorporated Buy 7.33% 17.98%
IRTC iRhythm Technologies, Inc. Buy 6.69% 9.2%
CARA Cara Therapeutics, Inc. Buy 5.85% -1.16%
ITGR Integer Holdings Corporation Buy 17.42% 2%
MDRX Allscripts Healthcare Solutions, Inc. Buy 7.5% 0%
BHVN Biohaven Ltd. Sell -3.26% -1.87%
COLL Collegium Pharmaceutical, Inc. Sell -3.08% 6.21%
VERU Veru Inc. Sell -3.44% 14.29%
CUTR Cutera, Inc. Sell -2.28% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.53% -5.38%
TNDM Tandem Diabetes Care, Inc. Sell -4.48% -2.52%
KIDS OrthoPediatrics Corp. Sell -4.25% 2.88%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.29% 1.81%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
Assets Removed
Asset Action Perf %
VCEL Sell All 34.9%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 7.2% 28.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.34% 13.07%
VREX Varex Imaging Corporation Buy 7.05% 17.52%
PTCT PTC Therapeutics, Inc. Buy 6.95% 12.61%
NUTX Nutex Health Inc. Buy 7.88% 27.16%
CDMO Avid Bioservices, Inc. Buy 7.57% 18.34%
IBRX ImmunityBio, Inc. Buy 6.97% 32.3%
HCSG Healthcare Services Group, Inc. Buy 6.78% 8.4%
IOVA Iovance Biotherapeutics, Inc. Buy 5.92% -3.99%
NEOG Neogen Corporation Buy 7.05% 13.18%
INCY Incyte Corporation Buy 6.99% 12.78%
ATEC Alphatec Holdings, Inc. Buy 7.19% 19.75%
MGNX MacroGenics, Inc. Buy 7.04% 12.4%
CORT Corcept Therapeutics Incorporated Buy 7.45% 19.06%
IRTC iRhythm Technologies, Inc. Buy 6.55% 6.19%
CARA Cara Therapeutics, Inc. Buy 5.88% -1.45%
ITGR Integer Holdings Corporation Buy 17.2% 0%
BHVN Biohaven Ltd. Sell -3.35% -3.89%
COLL Collegium Pharmaceutical, Inc. Sell -3.1% 6.27%
VERU Veru Inc. Sell -3.52% 13.1%
CUTR Cutera, Inc. Sell -2.3% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.53% -4.82%
TNDM Tandem Diabetes Care, Inc. Sell -4.4% 0%
KIDS OrthoPediatrics Corp. Sell -4.4% 0%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.4% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TNDM
  • KIDS
  • ENTA
  • ITGR
Assets Removed
Asset Action Perf %
EVH Buy All 42.39%
ARDX Sell All -16.06%
Assets Rebalanced
None
2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 7.42% 5.63%
VCEL Vericel Corporation Buy 6.82% 18.86%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.34% 10.49%
VREX Varex Imaging Corporation Buy 7.23% 17.93%
PTCT PTC Therapeutics, Inc. Buy 6.9% 9.26%
NUTX Nutex Health Inc. Buy 7.37% 16.4%
CDMO Avid Bioservices, Inc. Buy 7.73% 18.15%
IBRX ImmunityBio, Inc. Buy 6.78% 25.89%
HCSG Healthcare Services Group, Inc. Buy 6.86% 7.31%
IOVA Iovance Biotherapeutics, Inc. Buy 7.01% 11.33%
NEOG Neogen Corporation Buy 7% 10.04%
INCY Incyte Corporation Buy 7.05% 11.38%
ATEC Alphatec Holdings, Inc. Buy 7.36% 19.87%
MGNX MacroGenics, Inc. Buy 7.38% 15.25%
CORT Corcept Therapeutics Incorporated Buy 6.94% 8.47%
IRTC iRhythm Technologies, Inc. Buy 6.88% 8.99%
CARA Cara Therapeutics, Inc. Buy 6.1% 0%
BHVN Biohaven Ltd. Sell -3.4% -3.15%
EVH Evolent Health, Inc. Sell -3.26% -5.95%
COLL Collegium Pharmaceutical, Inc. Sell -3.42% -1.17%
VERU Veru Inc. Sell -3.6% 13.1%
CUTR Cutera, Inc. Sell -3.07% 8.93%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.42% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMPH
  • CARA
Assets Removed
Asset Action Perf %
CHRS Buy All -13.57%
NVRO Sell All -1.11%
Assets Rebalanced
None
2024-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 7.66% 7.45%
VCEL Vericel Corporation Buy 6.65% 14.14%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.42% 10.23%
VREX Varex Imaging Corporation Buy 7.44% 19.42%
PTCT PTC Therapeutics, Inc. Buy 7.04% 9.82%
NUTX Nutex Health Inc. Buy 7.04% 9.47%
CDMO Avid Bioservices, Inc. Buy 7.04% 5.98%
IBRX ImmunityBio, Inc. Buy 7.04% 28.74%
HCSG Healthcare Services Group, Inc. Buy 7.04% 8.49%
IOVA Iovance Biotherapeutics, Inc. Buy 7.04% 10.06%
NEOG Neogen Corporation Buy 7.04% 8.93%
NVRO Nevro Corp. Buy 7.04% 7.04%
INCY Incyte Corporation Buy 7.04% 9.5%
ATEC Alphatec Holdings, Inc. Buy 7.04% 12.99%
MGNX MacroGenics, Inc. Buy 7.04% 8.27%
CORT Corcept Therapeutics Incorporated Buy 7.04% 8.33%
IRTC iRhythm Technologies, Inc. Buy 7.04% 9.9%
BHVN Biohaven Ltd. Sell -3.49% -4.41%
EVH Evolent Health, Inc. Sell -3.34% -6.81%
COLL Collegium Pharmaceutical, Inc. Sell -3.45% -0.55%
CHRS Coherus BioSciences, Inc. Sell -4.22% -0.28%
VERU Veru Inc. Sell -3.7% 11.9%
CUTR Cutera, Inc. Sell -3.55% -3.57%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
SMTI Buy All -11.47%
Assets Rebalanced
Asset Action Weight
CORT Sell -0.71%
IRTC Sell -0.82%
NVRO Sell -1.11%
INCY Sell -1.3%
ATEC Sell -1.61%
IBRX Sell -1.63%
NEOG Sell -1.83%
HCSG Sell -3.62%
IOVA Sell -3.78%
VREX Buy 0.55%
ARDX Buy 0.78%
PTCT Buy 1.12%
NUTX Buy 1.14%
CDMO Buy 1.35%
MGNX Buy 6.49%
2024-11-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.15% -2.48%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.54% 3.62%
VCEL Vericel Corporation Buy 6.65% 5.42%
VREX Varex Imaging Corporation Buy 6.44% 9.5%
NUTX Nutex Health Inc. Buy 5.42% -7.17%
PTCT PTC Therapeutics, Inc. Buy 6% 2.72%
CDMO Avid Bioservices, Inc. Buy 5.8% -0.19%
IBRX ImmunityBio, Inc. Buy 9.01% 23.52%
HCSG Healthcare Services Group, Inc. Buy 10.86% 2.01%
IOVA Iovance Biotherapeutics, Inc. Buy 11.04% 3.72%
NEOG Neogen Corporation Buy 8.88% 0.63%
NVRO Nevro Corp. Buy 8.17% -0.93%
INCY Incyte Corporation Buy 8.45% 2.46%
ATEC Alphatec Holdings, Inc. Buy 8.83% 6.5%
MGNX MacroGenics, Inc. Buy 0.53% -4.39%
IRTC iRhythm Technologies, Inc. Buy 7.75% 0%
CORT Corcept Therapeutics Incorporated Buy 7.75% 0%
BHVN Biohaven Ltd. Sell -3.52% 2.78%
EVH Evolent Health, Inc. Sell -3.41% -0.73%
SMTI Sanara MedTech Inc. Sell -3.94% -6.02%
COLL Collegium Pharmaceutical, Inc. Sell -3.54% 4.63%
CHRS Coherus BioSciences, Inc. Sell -4.22% 7.2%
VERU Veru Inc. Sell -3.96% 13.1%
CUTR Cutera, Inc. Sell -3.71% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CUTR
  • IRTC
  • CORT
Assets Removed
Asset Action Perf %
AXSM Sell All -6.53%
VKTX Sell All -13.77%
Assets Rebalanced
None
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.35% 0.83%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.34% 0.67%
VCEL Vericel Corporation Buy 6.58% 4.51%
VREX Varex Imaging Corporation Buy 6.41% 9.09%
AXSM Axsome Therapeutics, Inc. Buy 5.59% -4.83%
NUTX Nutex Health Inc. Buy 5.31% -8.94%
PTCT PTC Therapeutics, Inc. Buy 6% 2.92%
CDMO Avid Bioservices, Inc. Buy 5.75% -0.87%
VKTX Viking Therapeutics, Inc. Buy 7.25% -0.46%
IBRX ImmunityBio, Inc. Buy 9.14% 25.42%
HCSG Healthcare Services Group, Inc. Buy 10.82% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 10.78% 1.45%
NEOG Neogen Corporation Buy 8.87% 0.7%
NVRO Nevro Corp. Buy 8.43% 2.41%
INCY Incyte Corporation Buy 8.48% 2.98%
ATEC Alphatec Holdings, Inc. Buy 8.55% 3.31%
MGNX MacroGenics, Inc. Buy 0.56% 0%
BHVN Biohaven Ltd. Sell -3.58% 1.15%
EVH Evolent Health, Inc. Sell -3.42% -1.16%
SMTI Sanara MedTech Inc. Sell -3.94% -6.21%
COLL Collegium Pharmaceutical, Inc. Sell -3.61% 2.48%
CHRS Coherus BioSciences, Inc. Sell -4.55% -0.14%
VERU Veru Inc. Sell -4.11% 9.52%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MGNX
Assets Removed
Asset Action Perf %
CUTR Buy All 21.33%
FATE Buy All 24.3%
IRWD Sell All -1.64%
Assets Rebalanced
None
2024-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.8% -7.28%
ARDX Ardelyx, Inc. Buy 6.29% -2.81%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.42% -0.67%
VCEL Vericel Corporation Buy 6.77% 4.63%
VREX Varex Imaging Corporation Buy 6.54% 8.51%
AXSM Axsome Therapeutics, Inc. Buy 5.75% -4.63%
NUTX Nutex Health Inc. Buy 5.38% -10.19%
PTCT PTC Therapeutics, Inc. Buy 6.08% 1.53%
CDMO Avid Bioservices, Inc. Buy 5.73% -3.86%
VKTX Viking Therapeutics, Inc. Buy 7.41% -0.93%
IBRX ImmunityBio, Inc. Buy 9.26% 23.75%
HCSG Healthcare Services Group, Inc. Buy 10.93% 0.18%
IOVA Iovance Biotherapeutics, Inc. Buy 10.33% -5.35%
NEOG Neogen Corporation Buy 9.01% -0.42%
NVRO Nevro Corp. Buy 8.63% 2.04%
INCY Incyte Corporation Buy 8.48% 0.26%
ATEC Alphatec Holdings, Inc. Buy 8.5% 0%
CUTR Cutera, Inc. Sell -2.77% 22.67%
FATE Fate Therapeutics, Inc. Sell -2.64% 26.17%
BHVN Biohaven Ltd. Sell -3.59% 3.32%
EVH Evolent Health, Inc. Sell -3.49% -0.69%
SMTI Sanara MedTech Inc. Sell -3.98% -4.6%
COLL Collegium Pharmaceutical, Inc. Sell -3.79% 0.5%
CHRS Coherus BioSciences, Inc. Sell -4.81% -3.19%
VERU Veru Inc. Sell -4.22% 9.52%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ATEC
Assets Removed
None
Assets Rebalanced
None
2024-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.97% -2.58%
ARDX Ardelyx, Inc. Buy 6.18% -2.48%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.45% 1.81%
VCEL Vericel Corporation Buy 6.86% 8.2%
VREX Varex Imaging Corporation Buy 6.52% 10.33%
AXSM Axsome Therapeutics, Inc. Buy 5.67% -4.17%
NUTX Nutex Health Inc. Buy 5.57% -5.16%
PTCT PTC Therapeutics, Inc. Buy 6.07% 3.41%
CDMO Avid Bioservices, Inc. Buy 5.72% -2.03%
VKTX Viking Therapeutics, Inc. Buy 7.19% -2.01%
IBRX ImmunityBio, Inc. Buy 9.82% 33.97%
HCSG Healthcare Services Group, Inc. Buy 10.8% 0.91%
IOVA Iovance Biotherapeutics, Inc. Buy 10.71% 0.09%
NEOG Neogen Corporation Buy 9.01% 1.6%
NVRO Nevro Corp. Buy 8.29% 0%
INCY Incyte Corporation Buy 8.29% 0%
CUTR Cutera, Inc. Sell -3% 14.67%
FATE Fate Therapeutics, Inc. Sell -2.72% 22.43%
BHVN Biohaven Ltd. Sell -3.57% 1.96%
EVH Evolent Health, Inc. Sell -3.54% -4.1%
SMTI Sanara MedTech Inc. Sell -3.87% -3.8%
COLL Collegium Pharmaceutical, Inc. Sell -3.77% -1.05%
CHRS Coherus BioSciences, Inc. Sell -4.75% -3.88%
VERU Veru Inc. Sell -4.19% 8.33%
The percentage of cash held in the portfolio is: 10.29%
New Assets Added
  • NVRO
  • INCY
Assets Removed
Asset Action Perf %
ALGN Sell All -2.57%
Assets Rebalanced
None
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.14% -0.23%
ARDX Ardelyx, Inc. Buy 6.33% -0.5%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.56% 3.2%
VCEL Vericel Corporation Buy 6.92% 8.89%
VREX Varex Imaging Corporation Buy 6.52% 10%
AXSM Axsome Therapeutics, Inc. Buy 5.74% -3.21%
NUTX Nutex Health Inc. Buy 5.24% -10.96%
PTCT PTC Therapeutics, Inc. Buy 6.36% 8.09%
CDMO Avid Bioservices, Inc. Buy 5.75% -1.74%
ALGN Align Technology, Inc. Buy 7.23% -1.68%
VKTX Viking Therapeutics, Inc. Buy 7.37% 0.18%
IBRX ImmunityBio, Inc. Buy 9.8% 33.25%
HCSG Healthcare Services Group, Inc. Buy 10.79% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 10.51% -1.99%
NEOG Neogen Corporation Buy 8.89% 0%
CUTR Cutera, Inc. Sell -3.14% 10.67%
FATE Fate Therapeutics, Inc. Sell -2.98% 15.26%
BHVN Biohaven Ltd. Sell -3.61% 1.01%
EVH Evolent Health, Inc. Sell -3.42% -0.34%
SMTI Sanara MedTech Inc. Sell -3.84% -2.69%
COLL Collegium Pharmaceutical, Inc. Sell -3.84% -2.71%
CHRS Coherus BioSciences, Inc. Sell -4.72% -2.91%
VERU Veru Inc. Sell -4.37% 4.76%
The percentage of cash held in the portfolio is: 19.78%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.93% -2.58%
ARDX Ardelyx, Inc. Buy 6.14% -2.32%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.55% 4.24%
VCEL Vericel Corporation Buy 6.82% 8.48%
VREX Varex Imaging Corporation Buy 6.37% 8.68%
NKTR Nektar Therapeutics Buy 5.5% -6.21%
AXSM Axsome Therapeutics, Inc. Buy 5.66% -3.47%
NUTX Nutex Health Inc. Buy 5.63% -3.3%
PTCT PTC Therapeutics, Inc. Buy 5.99% 2.95%
CDMO Avid Bioservices, Inc. Buy 5.65% -2.51%
ALGN Align Technology, Inc. Buy 7.25% -0.29%
VKTX Viking Therapeutics, Inc. Buy 7.4% 1.78%
IBRX ImmunityBio, Inc. Buy 10.66% 46.56%
HCSG Healthcare Services Group, Inc. Buy 10.61% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 10.61% 0%
CUTR Cutera, Inc. Sell -3.11% 10.67%
FATE Fate Therapeutics, Inc. Sell -3.11% 10.59%
BHVN Biohaven Ltd. Sell -3.63% -0.54%
EVH Evolent Health, Inc. Sell -3.43% -1.81%
SMTI Sanara MedTech Inc. Sell -3.85% -4.15%
COLL Collegium Pharmaceutical, Inc. Sell -3.79% -2.39%
CHRS Coherus BioSciences, Inc. Sell -4.54% 0%
VERU Veru Inc. Sell -4.54% 0%
The percentage of cash held in the portfolio is: 23.22%
New Assets Added
  • CHRS
  • VERU
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.95% -7.04%
ARDX Ardelyx, Inc. Buy 6.33% -4.47%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.87% 3.82%
VCEL Vericel Corporation Buy 6.88% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 10.24% 54.64%
VREX Varex Imaging Corporation Buy 6.59% 6.69%
NKTR Nektar Therapeutics Buy 5.62% -8.97%
AXSM Axsome Therapeutics, Inc. Buy 5.94% -3.73%
NUTX Nutex Health Inc. Buy 6% -2.14%
PTCT PTC Therapeutics, Inc. Buy 6.35% 3.64%
CDMO Avid Bioservices, Inc. Buy 5.89% -3.47%
ALGN Align Technology, Inc. Buy 7.76% 1.33%
VKTX Viking Therapeutics, Inc. Buy 8.16% 6.57%
IBRX ImmunityBio, Inc. Buy 9.68% 26.37%
CUTR Cutera, Inc. Sell -3.13% 14.67%
FATE Fate Therapeutics, Inc. Sell -3.03% 17.45%
BHVN Biohaven Ltd. Sell -3.9% -2.66%
EVH Evolent Health, Inc. Sell -3.68% -3.58%
SMTI Sanara MedTech Inc. Sell -3.92% -0.48%
COLL Collegium Pharmaceutical, Inc. Sell -3.94% -1.14%
The percentage of cash held in the portfolio is: 23.32%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All -9.09%
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.12% -6.57%
ORGO Organogenesis Holdings Inc. Buy 6.34% -6.82%
ARDX Ardelyx, Inc. Buy 6.57% -2.98%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.97% 2.94%
VCEL Vericel Corporation Buy 6.9% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 10.4% 53.61%
VREX Varex Imaging Corporation Buy 6.69% 5.95%
NKTR Nektar Therapeutics Buy 5.88% -6.9%
AXSM Axsome Therapeutics, Inc. Buy 6.01% -4.84%
NUTX Nutex Health Inc. Buy 6.21% -0.97%
PTCT PTC Therapeutics, Inc. Buy 6.6% 5.29%
CDMO Avid Bioservices, Inc. Buy 6.15% -1.45%
ALGN Align Technology, Inc. Buy 7.83% 0%
VKTX Viking Therapeutics, Inc. Buy 7.83% 0%
IBRX ImmunityBio, Inc. Buy 7.83% 0%
CUTR Cutera, Inc. Sell -3.25% 13.33%
FATE Fate Therapeutics, Inc. Sell -3.28% 12.46%
BHVN Biohaven Ltd. Sell -3.96% -1.73%
EVH Evolent Health, Inc. Sell -3.57% 1.81%
SMTI Sanara MedTech Inc. Sell -3.99% 0%
COLL Collegium Pharmaceutical, Inc. Sell -3.99% 0%
The percentage of cash held in the portfolio is: 17.67%
New Assets Added
  • SMTI
  • COLL
  • ALGN
  • VKTX
  • IBRX
Assets Removed
None
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.11% -6.57%
ORGO Organogenesis Holdings Inc. Buy 6.37% -6.17%
ARDX Ardelyx, Inc. Buy 6.25% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.96% 2.89%
VCEL Vericel Corporation Buy 6.79% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 10.73% 58.76%
VREX Varex Imaging Corporation Buy 6.64% 5.37%
NKTR Nektar Therapeutics Buy 6.13% -2.76%
AXSM Axsome Therapeutics, Inc. Buy 6.24% -1.1%
NUTX Nutex Health Inc. Buy 5.95% -4.88%
PTCT PTC Therapeutics, Inc. Buy 6.76% 8.04%
CDMO Avid Bioservices, Inc. Buy 6.23% 0%
CUTR Cutera, Inc. Sell -3.29% 12%
FATE Fate Therapeutics, Inc. Sell -3.53% 5.61%
BHVN Biohaven Ltd. Sell -3.98% -2.49%
EVH Evolent Health, Inc. Sell -3.5% 3.41%
The percentage of cash held in the portfolio is: 33.14%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.36% -4.23%
ORGO Organogenesis Holdings Inc. Buy 6.94% 0.65%
ARDX Ardelyx, Inc. Buy 6.57% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.23% 5.27%
VCEL Vericel Corporation Buy 6.82% -0.62%
CDXS Codexis, Inc. Buy 6.68% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 8.56% 24.74%
VREX Varex Imaging Corporation Buy 6.64% 3.64%
NKTR Nektar Therapeutics Buy 6.36% -0.69%
AXSM Axsome Therapeutics, Inc. Buy 6.34% -1.02%
NUTX Nutex Health Inc. Buy 6.36% 0%
PTCT PTC Therapeutics, Inc. Buy 6.36% 0%
CUTR Cutera, Inc. Sell -3.54% 6.8%
FATE Fate Therapeutics, Inc. Sell -3.78% 0.62%
BHVN Biohaven Ltd. Sell -4.03% -2.29%
EVH Evolent Health, Inc. Sell -3.64% 0.99%
The percentage of cash held in the portfolio is: 33.78%
New Assets Added
  • NUTX
  • PTCT
Assets Removed
Asset Action Perf %
IRTC Buy All -20.54%
LXRX Sell All -3.48%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.61% -1.64%
ORGO Organogenesis Holdings Inc. Buy 7.05% 0.97%
ARDX Ardelyx, Inc. Buy 6.77% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.36% 5.84%
VCEL Vericel Corporation Buy 6.8% -2.16%
CDXS Codexis, Inc. Buy 6.74% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 6.52% -6.19%
VREX Varex Imaging Corporation Buy 6.75% 4.13%
NKTR Nektar Therapeutics Buy 6.21% -4.14%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.29% -2.99%
AXSM Axsome Therapeutics, Inc. Buy 6.35% -1.98%
CUTR Cutera, Inc. Sell -3.59% 6.67%
FATE Fate Therapeutics, Inc. Sell -3.78% 1.87%
IRTC iRhythm Technologies, Inc. Sell -3.75% 0.97%
BHVN Biohaven Ltd. Sell -3.98% 0.25%
EVH Evolent Health, Inc. Sell -3.73% 0%
The percentage of cash held in the portfolio is: 45.38%
New Assets Added
  • EVH
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.91% 4.23%
ORGO Organogenesis Holdings Inc. Buy 6.86% -0.32%
ARDX Ardelyx, Inc. Buy 6.61% -3.48%
BKD Brookdale Senior Living Inc. Buy 7.49% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.38% 7.64%
VCEL Vericel Corporation Buy 6.62% -3.37%
CDXS Codexis, Inc. Buy 6.81% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 6.64% -3.09%
VREX Varex Imaging Corporation Buy 6.39% 0%
NKTR Nektar Therapeutics Buy 6.39% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.39% 0%
AXSM Axsome Therapeutics, Inc. Buy 6.39% 0%
CUTR Cutera, Inc. Sell -3.34% 12%
FATE Fate Therapeutics, Inc. Sell -3.8% -0.31%
IRTC iRhythm Technologies, Inc. Sell -3.72% 0.35%
BHVN Biohaven Ltd. Sell -3.95% -0.33%
The percentage of cash held in the portfolio is: 33.95%
New Assets Added
  • VREX
  • NKTR
  • LXRX
  • AXSM
Assets Removed
Asset Action Perf %
AXSM Buy All -7.81%
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.88% 5.63%
ORGO Organogenesis Holdings Inc. Buy 7.13% 5.52%
ARDX Ardelyx, Inc. Buy 6.52% -3.15%
BKD Brookdale Senior Living Inc. Buy 7.43% 10.41%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.34% 8.99%
VCEL Vericel Corporation Buy 6.6% -1.95%
RDNT RadNet, Inc. Buy 6.71% -0.34%
CDXS Codexis, Inc. Buy 6.99% 3.83%
SGMO Sangamo Therapeutics, Inc. Buy 6.88% 2.27%
CUTR Cutera, Inc. Sell -3.38% 9.25%
FATE Fate Therapeutics, Inc. Sell -3.73% 0%
IRTC iRhythm Technologies, Inc. Sell -3.61% 1.5%
AXSM Axsome Therapeutics, Inc. Sell -3.81% -3.9%
BHVN Biohaven Ltd. Sell -3.87% 0%
The percentage of cash held in the portfolio is: 55.91%
New Assets Added
  • BHVN
Assets Removed
Asset Action Perf %
ORMP Buy All -1.67%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.78% 3.05%
ORGO Organogenesis Holdings Inc. Buy 7.09% 3.9%
ARDX Ardelyx, Inc. Buy 6.72% -1.16%
BKD Brookdale Senior Living Inc. Buy 6.82% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.98% 2.69%
VCEL Vericel Corporation Buy 6.78% -0.33%
RDNT RadNet, Inc. Buy 6.81% 0.2%
CDXS Codexis, Inc. Buy 6.8% 0%
SGMO Sangamo Therapeutics, Inc. Buy 6.8% 0%
CUTR Cutera, Inc. Sell -3.46% 8%
FATE Fate Therapeutics, Inc. Sell -3.58% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -3.7% 1.67%
IRTC iRhythm Technologies, Inc. Sell -3.55% 4.11%
AXSM Axsome Therapeutics, Inc. Sell -3.7% 0.18%
The percentage of cash held in the portfolio is: 56.4%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.66% 0.7%
ORGO Organogenesis Holdings Inc. Buy 6.89% 0.32%
ARDX Ardelyx, Inc. Buy 6.78% -0.83%
BKD Brookdale Senior Living Inc. Buy 6.84% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.84% 0%
VCEL Vericel Corporation Buy 6.84% 0%
RDNT RadNet, Inc. Buy 6.84% 0%
CUTR Cutera, Inc. Sell -3.58% 5.33%
FATE Fate Therapeutics, Inc. Sell -3.6% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -3.77% 0.42%
IRTC iRhythm Technologies, Inc. Sell -3.44% 7.61%
AXSM Axsome Therapeutics, Inc. Sell -3.68% 1.35%
The percentage of cash held in the portfolio is: 70.38%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.64% 0%
ORGO Organogenesis Holdings Inc. Buy 6.87% -0.32%
ARDX Ardelyx, Inc. Buy 6.86% 0%
CUTR Cutera, Inc. Sell -3.85% -1.33%
FATE Fate Therapeutics, Inc. Sell -3.66% 3.74%
ORMP Oramed Pharmaceuticals Inc. Sell -3.78% 0.42%
IRTC iRhythm Technologies, Inc. Sell -3.4% 8.99%
AXSM Axsome Therapeutics, Inc. Sell -3.78% -1.12%
The percentage of cash held in the portfolio is: 98.1%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.54% -1.17%
ORGO Organogenesis Holdings Inc. Buy 6.74% -1.95%
CUTR Cutera, Inc. Sell -3.69% 2.67%
FATE Fate Therapeutics, Inc. Sell -3.47% 8.41%
ORMP Oramed Pharmaceuticals Inc. Sell -3.81% -0.42%
IRTC iRhythm Technologies, Inc. Sell -3.41% 8.5%
AXSM Axsome Therapeutics, Inc. Sell -3.58% 4.05%
The percentage of cash held in the portfolio is: 104.67%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.69% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 6.88% 0%
ORGO Organogenesis Holdings Inc. Buy 6.88% 0%
CUTR Cutera, Inc. Sell -3.79% 0%
FATE Fate Therapeutics, Inc. Sell -3.81% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -3.73% 1.67%
IRTC iRhythm Technologies, Inc. Sell -3.73% 0%
AXSM Axsome Therapeutics, Inc. Sell -3.73% 0%
The percentage of cash held in the portfolio is: 98.34%
New Assets Added
  • IRTC
  • AXSM
  • BCRX
  • ORGO
Assets Removed
Asset Action Perf %
CERS Buy All 19.43%
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.64% 0%
CERS Cerus Corporation Sell -3.42% 19.91%
CUTR Cutera, Inc. Sell -3.8% 0%
FATE Fate Therapeutics, Inc. Sell -3.8% 0%
ORMP Oramed Pharmaceuticals Inc. Sell -3.8% 0%
The percentage of cash held in the portfolio is: 108.17%
New Assets Added
  • CUTR
  • FATE
  • ORMP
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Sell -3.54% 17.06%
The percentage of cash held in the portfolio is: 103.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
LMAT Buy All -3%
AVXL Buy All 3.4%
PODD Sell All 13.51%
Assets Rebalanced
None
2024-09-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 10.49% 15.17%
LMAT LeMaitre Vascular, Inc. Sell -4.03% -1.4%
AVXL Anavex Life Sciences Corp. Sell -3.84% 3.57%
CERS Cerus Corporation Sell -3.6% 15.64%
The percentage of cash held in the portfolio is: 100.97%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All -4.63%
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 10.56% 16.82%
STAA STAAR Surgical Company Sell -3.86% 4.11%
LMAT LeMaitre Vascular, Inc. Sell -3.96% -0.25%
AVXL Anavex Life Sciences Corp. Sell -3.66% 7.31%
CERS Cerus Corporation Sell -3.55% 16.11%
The percentage of cash held in the portfolio is: 104.46%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 8.57%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.86% 8%
PODD Insulet Corporation Buy 10.59% 16.92%
NVCR NovoCure Limited Buy 7.21% -8.98%
STAA STAAR Surgical Company Sell -4.02% 0.25%
LMAT LeMaitre Vascular, Inc. Sell -4.05% -2.35%
AVXL Anavex Life Sciences Corp. Sell -3.74% 5.44%
CERS Cerus Corporation Sell -3.62% 14.69%
The percentage of cash held in the portfolio is: 90.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.9% 9.14%
PODD Insulet Corporation Buy 10.54% 16.9%
NVCR NovoCure Limited Buy 7.21% -8.42%
MYGN Myriad Genetics, Inc. Buy 7.47% -0.15%
STAA STAAR Surgical Company Sell -3.76% 6.21%
LMAT LeMaitre Vascular, Inc. Sell -4.04% -2.66%
AVXL Anavex Life Sciences Corp. Sell -3.67% 6.63%
CERS Cerus Corporation Sell -3.56% 15.64%
The percentage of cash held in the portfolio is: 82.91%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -10.93%
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.92% 10.29%
PODD Insulet Corporation Buy 10.35% 15.73%
ESPR Esperion Therapeutics, Inc. Buy 8.11% -8.2%
NVCR NovoCure Limited Buy 7.56% -3.32%
MYGN Myriad Genetics, Inc. Buy 7.61% 2.48%
STAA STAAR Surgical Company Sell -3.74% 6.12%
LMAT LeMaitre Vascular, Inc. Sell -3.95% -1.03%
AVXL Anavex Life Sciences Corp. Sell -3.75% 4.08%
CERS Cerus Corporation Sell -3.57% 14.69%
The percentage of cash held in the portfolio is: 74.44%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 6.76%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 6.59% 11.15%
AADI Aadi Bioscience, Inc. Buy 6.74% 7.43%
PODD Insulet Corporation Buy 10.24% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 8.5% -3.83%
NVCR NovoCure Limited Buy 7.78% -0.5%
MYGN Myriad Genetics, Inc. Buy 7.69% 3.45%
STAA STAAR Surgical Company Sell -3.86% 3.06%
LMAT LeMaitre Vascular, Inc. Sell -3.95% -1.08%
AVXL Anavex Life Sciences Corp. Sell -3.79% 3.06%
CERS Cerus Corporation Sell -4.09% 2.37%
The percentage of cash held in the portfolio is: 68.14%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -2.28%
APLS Sell All -8.89%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.8% -3.75%
AGEN Agenus Inc. Buy 6.22% 3.11%
AADI Aadi Bioscience, Inc. Buy 6.72% 5.14%
PODD Insulet Corporation Buy 10.15% 11.4%
MGNX MacroGenics, Inc. Buy 9.28% 3.13%
ESPR Esperion Therapeutics, Inc. Buy 8.55% -4.92%
TVTX Travere Therapeutics, Inc. Buy 8.84% 27.5%
NVCR NovoCure Limited Buy 7.6% -4.54%
MYGN Myriad Genetics, Inc. Buy 7.37% -2.56%
STAA STAAR Surgical Company Sell -3.79% 6.36%
LMAT LeMaitre Vascular, Inc. Sell -3.87% 2.57%
AVXL Anavex Life Sciences Corp. Sell -3.47% 12.76%
CERS Cerus Corporation Sell -4.14% 2.84%
The percentage of cash held in the portfolio is: 44.75%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 2.22%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.92% -1.69%
AGEN Agenus Inc. Buy 6.01% -0.18%
AADI Aadi Bioscience, Inc. Buy 6.49% 1.71%
PODD Insulet Corporation Buy 10.08% 10.8%
MGNX MacroGenics, Inc. Buy 9.11% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 8.49% -5.46%
TVTX Travere Therapeutics, Inc. Buy 9.27% 33.75%
NVCR NovoCure Limited Buy 7.45% -6.37%
MYGN Myriad Genetics, Inc. Buy 7.57% 0.26%
STAA STAAR Surgical Company Sell -3.77% 6.89%
LMAT LeMaitre Vascular, Inc. Sell -3.85% 3.03%
AVXL Anavex Life Sciences Corp. Sell -3.38% 14.88%
VREX Varex Imaging Corporation Sell -4.13% 2.99%
CERS Cerus Corporation Sell -4.14% 2.84%
The percentage of cash held in the portfolio is: 48.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All 0.85%
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.01% 0.21%
CARA Cara Therapeutics, Inc. Buy 5.42% -9.62%
AGEN Agenus Inc. Buy 5.62% -6.22%
AADI Aadi Bioscience, Inc. Buy 6.57% 3.43%
PODD Insulet Corporation Buy 9.71% 7.2%
MGNX MacroGenics, Inc. Buy 8.79% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 8.31% -7.1%
TVTX Travere Therapeutics, Inc. Buy 9.24% 33.96%
NVCR NovoCure Limited Buy 7.28% -7.98%
MYGN Myriad Genetics, Inc. Buy 7.57% 0.63%
CDMO Avid Bioservices, Inc. Sell -3.36% 15.41%
STAA STAAR Surgical Company Sell -3.74% 7.17%
LMAT LeMaitre Vascular, Inc. Sell -3.84% 2.83%
AVXL Anavex Life Sciences Corp. Sell -3.46% 12.41%
VREX Varex Imaging Corporation Sell -3.71% 12.56%
CERS Cerus Corporation Sell -4.06% 4.27%
The percentage of cash held in the portfolio is: 47.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
BGNE Buy All -0.8%
PACB Buy All -22.96%
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.3% 3%
CARA Cara Therapeutics, Inc. Buy 5.75% -6.12%
AGEN Agenus Inc. Buy 5.54% -9.51%
AADI Aadi Bioscience, Inc. Buy 6.78% 4.57%
PODD Insulet Corporation Buy 9.71% 5.05%
MGNX MacroGenics, Inc. Buy 8.46% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 8.23% -9.84%
TVTX Travere Therapeutics, Inc. Buy 8.05% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 7.86% -3.01%
NVCR NovoCure Limited Buy 7.56% -6.48%
MYGN Myriad Genetics, Inc. Buy 7.68% 0%
CDMO Avid Bioservices, Inc. Sell -3.39% 16.54%
STAA STAAR Surgical Company Sell -3.95% 3.86%
LMAT LeMaitre Vascular, Inc. Sell -3.99% 1.1%
AVXL Anavex Life Sciences Corp. Sell -3.54% 12.41%
PACB Pacific Biosciences of California, Inc. Sell -4.73% -17.04%
BGNE BeiGene, Ltd. Sell -2.25% 0.24%
VREX Varex Imaging Corporation Sell -4.27% 1.28%
CERS Cerus Corporation Sell -4.14% 4.27%
The percentage of cash held in the portfolio is: 48.34%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.99% -1.42%
ORGO Organogenesis Holdings Inc. Buy 5.67% -6.71%
CARA Cara Therapeutics, Inc. Buy 5.69% -6.41%
AGEN Agenus Inc. Buy 5.56% -8.59%
AADI Aadi Bioscience, Inc. Buy 6.63% 2.86%
PODD Insulet Corporation Buy 9.71% 5.72%
MGNX MacroGenics, Inc. Buy 8.74% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 8.53% -6.01%
TVTX Travere Therapeutics, Inc. Buy 7.23% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 8.05% 0%
NVCR NovoCure Limited Buy 8.03% 0%
CDMO Avid Bioservices, Inc. Sell -3.43% 14.93%
STAA STAAR Surgical Company Sell -3.94% 3.61%
LMAT LeMaitre Vascular, Inc. Sell -3.97% 1.07%
AVXL Anavex Life Sciences Corp. Sell -3.79% 5.44%
PACB Pacific Biosciences of California, Inc. Sell -4.16% -3.7%
BGNE BeiGene, Ltd. Sell -2.24% 0.1%
VREX Varex Imaging Corporation Sell -4.4% -2.31%
CERS Cerus Corporation Sell -4.24% 1.42%
The percentage of cash held in the portfolio is: 50.33%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% -5.21%
ORGO Organogenesis Holdings Inc. Buy 5.79% -4.59%
CARA Cara Therapeutics, Inc. Buy 5.7% -6.12%
AGEN Agenus Inc. Buy 5.38% -11.33%
AADI Aadi Bioscience, Inc. Buy 6.62% 2.86%
PODD Insulet Corporation Buy 9.54% 3.96%
MGNX MacroGenics, Inc. Buy 8.57% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 9.01% -0.55%
TVTX Travere Therapeutics, Inc. Buy 7.31% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 8.04% 0%
CDMO Avid Bioservices, Inc. Sell -3.52% 12.67%
STAA STAAR Surgical Company Sell -3.97% 2.72%
LMAT LeMaitre Vascular, Inc. Sell -3.98% 0.61%
AVXL Anavex Life Sciences Corp. Sell -3.83% 4.42%
PACB Pacific Biosciences of California, Inc. Sell -3.92% 2.22%
BGNE BeiGene, Ltd. Sell -2.2% 1.63%
VREX Varex Imaging Corporation Sell -4.29% 0%
CERS Cerus Corporation Sell -4.29% 0%
The percentage of cash held in the portfolio is: 58.28%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.93% -2.65%
ORGO Organogenesis Holdings Inc. Buy 5.87% -3.53%
CARA Cara Therapeutics, Inc. Buy 5.88% -3.5%
AGEN Agenus Inc. Buy 5.51% -9.51%
CERS Cerus Corporation Buy 5.94% -7.98%
AADI Aadi Bioscience, Inc. Buy 6.41% -0.57%
PODD Insulet Corporation Buy 9.3% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.24% -10.38%
MGNX MacroGenics, Inc. Buy 8.49% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 9.08% 0%
TVTX Travere Therapeutics, Inc. Buy 7% 0%
CDMO Avid Bioservices, Inc. Sell -3.71% 8.03%
STAA STAAR Surgical Company Sell -4.08% 0.15%
LMAT LeMaitre Vascular, Inc. Sell -3.95% 1.75%
AVXL Anavex Life Sciences Corp. Sell -3.73% 7.14%
PACB Pacific Biosciences of California, Inc. Sell -3.99% 0.74%
BGNE BeiGene, Ltd. Sell -2.2% 1.84%
The percentage of cash held in the portfolio is: 44.01%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.72% -2.98%
APLS Apellis Pharmaceuticals, Inc. Buy 5.75% -2.4%
ORGO Organogenesis Holdings Inc. Buy 6% 1.77%
CARA Cara Therapeutics, Inc. Buy 6.19% 4.96%
AGEN Agenus Inc. Buy 5.55% -5.85%
CERS Cerus Corporation Buy 5.93% -5.04%
AADI Aadi Bioscience, Inc. Buy 6.46% 3.43%
NEOG Neogen Corporation Buy 7.2% 0.35%
PODD Insulet Corporation Buy 8.83% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.8% -1.15%
MGNX MacroGenics, Inc. Buy 8.79% 0%
ESPR Esperion Therapeutics, Inc. Buy 8.79% 0%
CDMO Avid Bioservices, Inc. Sell -3.89% 0.38%
STAA STAAR Surgical Company Sell -4.05% -2.22%
PINC Premier, Inc. Sell -4.08% -2.93%
LMAT LeMaitre Vascular, Inc. Sell -3.94% -1.4%
AVXL Anavex Life Sciences Corp. Sell -3.98% -2.38%
VERU Veru Inc. Sell -3.94% -1.23%
PACB Pacific Biosciences of California, Inc. Sell -3.95% -1.48%
BGNE BeiGene, Ltd. Sell -2.17% 0%
The percentage of cash held in the portfolio is: 45.97%
New Assets Added
  • BGNE
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.67% -3.77%
APLS Apellis Pharmaceuticals, Inc. Buy 5.72% -2.85%
ORGO Organogenesis Holdings Inc. Buy 6.03% 2.47%
CARA Cara Therapeutics, Inc. Buy 6.04% 2.62%
AGEN Agenus Inc. Buy 5.37% -8.78%
CERS Cerus Corporation Buy 6% -3.78%
AADI Aadi Bioscience, Inc. Buy 6.24% 0%
NEOG Neogen Corporation Buy 7.14% -0.41%
PODD Insulet Corporation Buy 8.93% 0.36%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.97% 0.77%
CDMO Avid Bioservices, Inc. Sell -3.82% 2.08%
STAA STAAR Surgical Company Sell -3.93% 0.71%
PINC Premier, Inc. Sell -4.04% -2.07%
LMAT LeMaitre Vascular, Inc. Sell -3.87% 0.47%
AVXL Anavex Life Sciences Corp. Sell -3.94% -1.53%
VERU Veru Inc. Sell -3.93% -1.23%
PACB Pacific Biosciences of California, Inc. Sell -3.91% -0.74%
The percentage of cash held in the portfolio is: 61.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
LXRX Buy All 19.28%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.69% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 5.64% -4.2%
ORGO Organogenesis Holdings Inc. Buy 6.1% 3.53%
CARA Cara Therapeutics, Inc. Buy 6.11% 3.79%
AGEN Agenus Inc. Buy 5.5% -6.58%
CERS Cerus Corporation Buy 5.87% -5.88%
AADI Aadi Bioscience, Inc. Buy 5.99% -4%
NEOG Neogen Corporation Buy 7.01% -2.15%
PODD Insulet Corporation Buy 8.9% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.9% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.82% 22.87%
CDMO Avid Bioservices, Inc. Sell -3.77% 3.4%
STAA STAAR Surgical Company Sell -3.9% 1.42%
PINC Premier, Inc. Sell -3.97% -0.3%
LMAT LeMaitre Vascular, Inc. Sell -3.88% 0%
AVXL Anavex Life Sciences Corp. Sell -3.88% 0%
VERU Veru Inc. Sell -3.88% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.88% 0%
The percentage of cash held in the portfolio is: 64.28%
New Assets Added
  • LMAT
  • AVXL
  • VERU
  • PACB
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.68% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 5.78% -0.64%
ORGO Organogenesis Holdings Inc. Buy 6.05% 3.89%
CARA Cara Therapeutics, Inc. Buy 6.09% 4.66%
AGEN Agenus Inc. Buy 5.99% 2.93%
CERS Cerus Corporation Buy 6.01% -2.52%
AADI Aadi Bioscience, Inc. Buy 5.92% -4%
NEOG Neogen Corporation Buy 7.08% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.78% 22.87%
CDMO Avid Bioservices, Inc. Sell -3.75% 2.74%
STAA STAAR Surgical Company Sell -3.91% 0%
PINC Premier, Inc. Sell -3.91% 0%
The percentage of cash held in the portfolio is: 65.75%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
Asset Action Perf %
CYH Sell All 4.72%
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.5% 6.09%
ARDX Ardelyx, Inc. Buy 5.7% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 5.75% -0.05%
ORGO Organogenesis Holdings Inc. Buy 6.16% 7.07%
CARA Cara Therapeutics, Inc. Buy 6.21% 7.87%
AGEN Agenus Inc. Buy 6.18% 7.31%
CERS Cerus Corporation Buy 6.1% 0%
AADI Aadi Bioscience, Inc. Buy 6.1% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.83% 20.63%
CDMO Avid Bioservices, Inc. Sell -3.74% 2.08%
The percentage of cash held in the portfolio is: 56.87%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.12% -0.59%
ARDX Ardelyx, Inc. Buy 5.81% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 5.86% 0.64%
ORGO Organogenesis Holdings Inc. Buy 6.03% 3.53%
CARA Cara Therapeutics, Inc. Buy 5.91% 1.46%
AGEN Agenus Inc. Buy 6.18% 6.03%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.97% 17.94%
CDMO Avid Bioservices, Inc. Sell -3.86% 0%
The percentage of cash held in the portfolio is: 69.92%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.96% -4.32%
ARDX Ardelyx, Inc. Buy 5.62% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 5.81% -1.79%
ORGO Organogenesis Holdings Inc. Buy 5.75% -2.83%
CARA Cara Therapeutics, Inc. Buy 5.91% 0%
AGEN Agenus Inc. Buy 5.91% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.01% 17.94%
The percentage of cash held in the portfolio is: 67.06%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.02% -2.95%
ARDX Ardelyx, Inc. Buy 5.88% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 5.88% 0%
ORGO Organogenesis Holdings Inc. Buy 5.88% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.12% 14.35%
The percentage of cash held in the portfolio is: 78.46%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.08% -1.57%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.7% 25.56%
The percentage of cash held in the portfolio is: 95.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
EGRX Buy All 4.43%
NKTR Buy All 7.41%
RCM Sell All 7.37%
Assets Rebalanced
None
2024-08-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 6.55% 7.37%
CYH Community Health Systems, Inc. Buy 6.8% -4.91%
NKTR Nektar Therapeutics Sell -3.02% 17.78%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.59% 28.25%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.11% 13.71%
The percentage of cash held in the portfolio is: 95.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All 13.64%
AVNS Sell All 6.33%
SGRY Sell All 16.4%
RGNX Sell All -8.1%
ANGO Sell All 21.37%
Assets Rebalanced
None
2024-08-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.7% 8.33%
AVNS Avanos Medical, Inc. Buy 6.52% 8.69%
SGRY Surgery Partners, Inc. Buy 7.04% 17.34%
RGNX REGENXBIO Inc. Buy 5.05% -6.45%
ANGO AngioDynamics, Inc. Buy 7.56% 23.82%
RCM R1 RCM Inc. Buy 6.55% 7.21%
CYH Community Health Systems, Inc. Buy 6.95% -2.95%
NKTR Nektar Therapeutics Sell -3.3% 10.37%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.72% 24.66%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.16% 12.45%
The percentage of cash held in the portfolio is: 63.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
CPRX Buy All -6.15%
PODD Buy All -2.48%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.15% -3.03%
AVNS Avanos Medical, Inc. Buy 6.42% 6.19%
SGRY Surgery Partners, Inc. Buy 6.77% 11.98%
RGNX REGENXBIO Inc. Buy 5.16% -5.27%
ANGO AngioDynamics, Inc. Buy 7.26% 17.78%
RCM R1 RCM Inc. Buy 6.6% 7.14%
CYH Community Health Systems, Inc. Buy 6.67% -7.66%
PODD Insulet Corporation Sell -3.63% 2.34%
NKTR Nektar Therapeutics Sell -3.25% 12.59%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.55% 30.04%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.27% 10.34%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.83% 5.86%
The percentage of cash held in the portfolio is: 72.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Buy All -20.7%
RMD Sell All 1.39%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.14% -0.76%
AVNS Avanos Medical, Inc. Buy 6.39% 8.36%
SGRY Surgery Partners, Inc. Buy 6.63% 12.41%
RGNX REGENXBIO Inc. Buy 5.23% -1.57%
ANGO AngioDynamics, Inc. Buy 7.33% 22.02%
RCM R1 RCM Inc. Buy 6.43% 7.06%
CYH Community Health Systems, Inc. Buy 6.67% -5.3%
RMD ResMed Inc. Buy 13.94% 3.67%
PODD Insulet Corporation Sell -3.54% 2.25%
NKTR Nektar Therapeutics Sell -3.14% 13.33%
INGN Inogen, Inc. Sell -3.17% 10.89%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.42% 31.84%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.27% 8.02%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.56% 10.15%
The percentage of cash held in the portfolio is: 61.35%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All -10.51%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.25% 2.27%
PDSB PDS Biotechnology Corporation Buy 4.12% -8.52%
AVNS Avanos Medical, Inc. Buy 6.63% 13.36%
SGRY Surgery Partners, Inc. Buy 6.65% 13.78%
RGNX REGENXBIO Inc. Buy 5.4% 2.6%
ANGO AngioDynamics, Inc. Buy 7.55% 26.75%
RCM R1 RCM Inc. Buy 6.42% 7.83%
CYH Community Health Systems, Inc. Buy 6.85% -1.96%
RMD ResMed Inc. Buy 14.32% 7.5%
PODD Insulet Corporation Sell -3.62% -0.76%
NKTR Nektar Therapeutics Sell -3.19% 11.11%
INGN Inogen, Inc. Sell -3.28% 6.97%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.69% 23.77%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.42% 2.95%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.75% 4.47%
The percentage of cash held in the portfolio is: 56.77%
New Assets Added
None
Assets Removed
Asset Action Perf %
RARE Buy All -17.98%
CUTR Sell All -19.59%
HQY Sell All -11.82%
SAVA Sell All 95.11%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.49% 4.55%
PDSB PDS Biotechnology Corporation Buy 4.23% -8.24%
AVNS Avanos Medical, Inc. Buy 6.71% 12.13%
SGRY Surgery Partners, Inc. Buy 7.08% 18.28%
RGNX REGENXBIO Inc. Buy 5.64% 4.72%
ANGO AngioDynamics, Inc. Buy 7.75% 27.08%
CUTR Cutera, Inc. Buy 4.59% -12.16%
RCM R1 RCM Inc. Buy 6.61% 8.44%
CYH Community Health Systems, Inc. Buy 7.04% -1.57%
HQY HealthEquity, Inc. Buy 6.87% -3.84%
SAVA Cassava Sciences, Inc. Buy 11.26% 57.44%
HCSG Healthcare Services Group, Inc. Buy 2.46% -3.72%
RMD ResMed Inc. Buy 14.06% 3.13%
PODD Insulet Corporation Sell -3.72% -1.17%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.79% -3.2%
NKTR Nektar Therapeutics Sell -3.46% 5.93%
INGN Inogen, Inc. Sell -3.58% 0.87%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.27% 9.42%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.64% -0.84%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.95% 1.8%
The percentage of cash held in the portfolio is: 35.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -12.39%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.62% 7.58%
PDSB PDS Biotechnology Corporation Buy 4.64% 1.14%
AVNS Avanos Medical, Inc. Buy 6.72% 12.94%
SGRY Surgery Partners, Inc. Buy 7.07% 18.83%
RGNX REGENXBIO Inc. Buy 6.01% 12.12%
ANGO AngioDynamics, Inc. Buy 7.75% 27.9%
CUTR Cutera, Inc. Buy 4.92% -5.41%
RCM R1 RCM Inc. Buy 5.99% -1.15%
FATE Fate Therapeutics, Inc. Buy 7.67% -4.31%
CYH Community Health Systems, Inc. Buy 7.35% 3.34%
HQY HealthEquity, Inc. Buy 6.89% -3.09%
SAVA Cassava Sciences, Inc. Buy 10.59% 48.93%
HCSG Healthcare Services Group, Inc. Buy 2.51% -1.12%
RMD ResMed Inc. Buy 13.9% 2.5%
PODD Insulet Corporation Sell -3.64% 0.31%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.85% -5.24%
NKTR Nektar Therapeutics Sell -3.63% 0.74%
INGN Inogen, Inc. Sell -3.61% -0.76%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.62% -0.9%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.65% -1.69%
CPRX Catalyst Pharmaceuticals, Inc. Sell -4% 0%
The percentage of cash held in the portfolio is: 28.38%
New Assets Added
  • CPRX
Assets Removed
Asset Action Perf %
SMTI Buy All -6.87%
VRDN Sell All 27.55%
RYTM Sell All 12.98%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 7% 26.42%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.94% 11.69%
OPK OPKO Health, Inc. Buy 5.82% 8.33%
PDSB PDS Biotechnology Corporation Buy 4.64% -1.7%
AVNS Avanos Medical, Inc. Buy 6.64% 8.4%
SGRY Surgery Partners, Inc. Buy 7.49% 22.27%
RGNX REGENXBIO Inc. Buy 6.2% 12.43%
ANGO AngioDynamics, Inc. Buy 7.97% 27.73%
CUTR Cutera, Inc. Buy 5.2% -2.7%
RCM R1 RCM Inc. Buy 6.18% -1%
FATE Fate Therapeutics, Inc. Buy 7.6% -7.9%
CYH Community Health Systems, Inc. Buy 7.42% 1.38%
HQY HealthEquity, Inc. Buy 7.08% -3.16%
SAVA Cassava Sciences, Inc. Buy 8.61% 17.76%
HCSG Healthcare Services Group, Inc. Buy 2.6% -0.43%
RMD ResMed Inc. Buy 13.95% 0%
PODD Insulet Corporation Sell -3.74% 0.6%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.93% -4.51%
NKTR Nektar Therapeutics Sell -3.87% -2.96%
SMTI Sanara MedTech Inc. Sell -3.69% 0%
INGN Inogen, Inc. Sell -3.69% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.69% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.69% 0%
The percentage of cash held in the portfolio is: 15.95%
New Assets Added
  • SMTI
  • INGN
  • LXRX
  • EGRX
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 7.1% 30.89%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.95% 14.23%
OPK OPKO Health, Inc. Buy 5.7% 8.33%
PDSB PDS Biotechnology Corporation Buy 5.02% 8.52%
AVNS Avanos Medical, Inc. Buy 6.48% 8.03%
SGRY Surgery Partners, Inc. Buy 7.3% 21.76%
RGNX REGENXBIO Inc. Buy 6.1% 12.9%
ANGO AngioDynamics, Inc. Buy 7.63% 24.96%
CUTR Cutera, Inc. Buy 4.95% -5.41%
RCM R1 RCM Inc. Buy 5.95% -2.61%
FATE Fate Therapeutics, Inc. Buy 7.85% -2.87%
CLDX Celldex Therapeutics, Inc. Buy 6.87% -4.26%
SMTI Sanara MedTech Inc. Buy 6.77% -5.45%
CYH Community Health Systems, Inc. Buy 7.29% 1.77%
HQY HealthEquity, Inc. Buy 7.04% -1.69%
SAVA Cassava Sciences, Inc. Buy 8.65% 20.78%
HCSG Healthcare Services Group, Inc. Buy 2.56% 0%
PODD Insulet Corporation Sell -3.63% 1.61%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.9% -5.75%
NKTR Nektar Therapeutics Sell -3.71% -0.74%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
RMD Buy All -5.84%
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 6.8% 26.12%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.95% 14.95%
OPK OPKO Health, Inc. Buy 5.86% 12.12%
PDSB PDS Biotechnology Corporation Buy 5.06% 10.23%
AVNS Avanos Medical, Inc. Buy 6.51% 9.25%
SGRY Surgery Partners, Inc. Buy 7.46% 25.32%
RGNX REGENXBIO Inc. Buy 6.05% 12.75%
ANGO AngioDynamics, Inc. Buy 7.57% 24.8%
CUTR Cutera, Inc. Buy 5.34% 2.7%
RCM R1 RCM Inc. Buy 6.06% -0.19%
FATE Fate Therapeutics, Inc. Buy 7.84% -2.33%
PTGX Protagonist Therapeutics, Inc. Buy 6.75% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 7.24% 1.6%
SMTI Sanara MedTech Inc. Buy 7.12% 0%
CYH Community Health Systems, Inc. Buy 7.12% 0%
HQY HealthEquity, Inc. Buy 7.12% 0%
SAVA Cassava Sciences, Inc. Buy 7.12% 0%
PODD Insulet Corporation Sell -3.63% 0.85%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.84% -4.86%
NKTR Nektar Therapeutics Sell -3.74% -2.22%
RMD ResMed Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RMD
  • SMTI
  • CYH
  • HQY
  • SAVA
Assets Removed
Asset Action Perf %
WAT Buy All -5.03%
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 6.73% 23.69%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.08% 16.26%
OPK OPKO Health, Inc. Buy 5.68% 7.58%
PDSB PDS Biotechnology Corporation Buy 5.19% 11.93%
AVNS Avanos Medical, Inc. Buy 6.51% 8.22%
SGRY Surgery Partners, Inc. Buy 7.24% 20.35%
RGNX REGENXBIO Inc. Buy 6.13% 13.22%
ANGO AngioDynamics, Inc. Buy 7.51% 22.51%
CUTR Cutera, Inc. Buy 4.97% -5.41%
RCM R1 RCM Inc. Buy 6.08% -0.84%
FATE Fate Therapeutics, Inc. Buy 7.86% -3.05%
PTGX Protagonist Therapeutics, Inc. Buy 7.04% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 7.2% 0%
PODD Insulet Corporation Sell -3.62% 2.09%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.89% -5.33%
NKTR Nektar Therapeutics Sell -3.75% -1.48%
WAT Waters Corporation Sell -3.74% -2.5%
The percentage of cash held in the portfolio is: 30.8%
New Assets Added
  • CLDX
Assets Removed
Asset Action Perf %
CYH Sell All 48.75%
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.14% 35.31%
VRDN Viridian Therapeutics, Inc. Buy 6.66% 19.76%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.18% 15.58%
OPK OPKO Health, Inc. Buy 5.8% 7.58%
PDSB PDS Biotechnology Corporation Buy 5.07% 6.96%
AVNS Avanos Medical, Inc. Buy 6.56% 6.7%
SGRY Surgery Partners, Inc. Buy 7.14% 16.16%
RGNX REGENXBIO Inc. Buy 5.94% 7.32%
ANGO AngioDynamics, Inc. Buy 7.49% 19.58%
CUTR Cutera, Inc. Buy 5.22% -2.7%
RCM R1 RCM Inc. Buy 6.32% 0.92%
FATE Fate Therapeutics, Inc. Buy 7.71% -7%
PTGX Protagonist Therapeutics, Inc. Buy 7.25% 0%
PODD Insulet Corporation Sell -3.77% 0.3%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.98% -5.45%
NKTR Nektar Therapeutics Sell -3.94% -4.44%
WAT Waters Corporation Sell -3.76% -0.86%
The percentage of cash held in the portfolio is: 30.99%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
EGRX Sell All 20.09%
ACAD Sell All 16.37%
Assets Rebalanced
None
2024-07-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 5.92% 28.79%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.59% 14.55%
CYH Community Health Systems, Inc. Buy 6.59% 26.56%
VRDN Viridian Therapeutics, Inc. Buy 6.48% 18.17%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.15% 16.71%
OPK OPKO Health, Inc. Buy 5.81% 9.09%
PDSB PDS Biotechnology Corporation Buy 5.62% 20.17%
AVNS Avanos Medical, Inc. Buy 6.5% 7.18%
SGRY Surgery Partners, Inc. Buy 6.73% 10.92%
RGNX REGENXBIO Inc. Buy 5.8% 6.22%
ANGO AngioDynamics, Inc. Buy 7.54% 22.02%
CUTR Cutera, Inc. Buy 5.65% 6.76%
RCM R1 RCM Inc. Buy 6.37% 3.07%
FATE Fate Therapeutics, Inc. Buy 8.17% 0%
PODD Insulet Corporation Sell -3.76% -0.92%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.94% -5.61%
NKTR Nektar Therapeutics Sell -4.08% -9.63%
WAT Waters Corporation Sell -3.66% 0.62%
The percentage of cash held in the portfolio is: 26.52%
New Assets Added
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 6.02% 29.24%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.65% 14.17%
CYH Community Health Systems, Inc. Buy 6.51% 23.44%
VRDN Viridian Therapeutics, Inc. Buy 6.3% 13.4%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.23% 16.66%
OPK OPKO Health, Inc. Buy 5.97% 10.61%
PDSB PDS Biotechnology Corporation Buy 5.25% 10.8%
AVNS Avanos Medical, Inc. Buy 6.53% 6.28%
SGRY Surgery Partners, Inc. Buy 6.78% 10.29%
RGNX REGENXBIO Inc. Buy 5.56% 0.47%
ANGO AngioDynamics, Inc. Buy 7.28% 16.31%
CUTR Cutera, Inc. Buy 5.91% 10.14%
RCM R1 RCM Inc. Buy 6.4% 2.15%
PODD Insulet Corporation Sell -3.76% 0.37%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.92% -3.93%
NKTR Nektar Therapeutics Sell -4.08% -8.15%
WAT Waters Corporation Sell -3.79% -1.49%
The percentage of cash held in the portfolio is: 35.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Buy All -22.33%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 6.07% 31.03%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.5% 11.78%
CYH Community Health Systems, Inc. Buy 6.18% 17.81%
VRDN Viridian Therapeutics, Inc. Buy 6.06% 9.54%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.17% 16.17%
OPK OPKO Health, Inc. Buy 6.06% 12.88%
PDSB PDS Biotechnology Corporation Buy 5.18% 9.94%
AVNS Avanos Medical, Inc. Buy 6.35% 3.82%
SGRY Surgery Partners, Inc. Buy 6.95% 13.7%
RGNX REGENXBIO Inc. Buy 5.45% -1.02%
ANGO AngioDynamics, Inc. Buy 7.29% 17.13%
CUTR Cutera, Inc. Buy 5.73% 7.43%
RCM R1 RCM Inc. Buy 6.35% 2%
FGEN FibroGen, Inc. Sell -3.8% -1.94%
PODD Insulet Corporation Sell -3.76% -0.04%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.74% 0.54%
NKTR Nektar Therapeutics Sell -3.87% -2.96%
WAT Waters Corporation Sell -3.71% 0%
The percentage of cash held in the portfolio is: 39.53%
New Assets Added
  • WAT
Assets Removed
Asset Action Perf %
TDOC Sell All -2.99%
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 5.95% 28.57%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.56% 13.35%
CYH Community Health Systems, Inc. Buy 6.17% 17.81%
VRDN Viridian Therapeutics, Inc. Buy 6.05% 9.54%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.12% 15.44%
OPK OPKO Health, Inc. Buy 6.17% 15.15%
ALT Altimmune, Inc. Buy 5.15% -12.43%
PDSB PDS Biotechnology Corporation Buy 5.16% 9.66%
AVNS Avanos Medical, Inc. Buy 6.46% 5.95%
TDOC Teladoc Health, Inc. Buy 6.06% -0.64%
SGRY Surgery Partners, Inc. Buy 6.95% 13.89%
RGNX REGENXBIO Inc. Buy 5.56% 1.1%
ANGO AngioDynamics, Inc. Buy 7.05% 13.38%
CUTR Cutera, Inc. Buy 5.58% 4.73%
RCM R1 RCM Inc. Buy 6.13% -1.46%
FGEN FibroGen, Inc. Sell -3.76% -0.97%
PODD Insulet Corporation Sell -3.75% 0%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.75% 0%
NKTR Nektar Therapeutics Sell -3.75% 0%
The percentage of cash held in the portfolio is: 24.9%
New Assets Added
  • PODD
  • RARE
  • NKTR
Assets Removed
Asset Action Perf %
RARE Sell All 7.35%
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 5.95% 33.48%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.46% 15.55%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.71% 10.14%
CYH Community Health Systems, Inc. Buy 6.21% 23.12%
VRDN Viridian Therapeutics, Inc. Buy 6.13% 15.37%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.23% 22.05%
OPK OPKO Health, Inc. Buy 5.55% 7.58%
ALT Altimmune, Inc. Buy 5.68% 0.13%
PDSB PDS Biotechnology Corporation Buy 5.16% 13.92%
WST West Pharmaceutical Services, Inc. Buy 5.76% -1.88%
AVNS Avanos Medical, Inc. Buy 6.28% 6.89%
TDOC Teladoc Health, Inc. Buy 6.29% 7.04%
SGRY Surgery Partners, Inc. Buy 6.79% 15.66%
RGNX REGENXBIO Inc. Buy 5.53% 4.48%
ANGO AngioDynamics, Inc. Buy 7.22% 20.72%
CUTR Cutera, Inc. Buy 5.79% 12.84%
RCM R1 RCM Inc. Buy 5.98% 0%
FGEN FibroGen, Inc. Sell -3.72% -3.88%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 6.14% 33.26%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.55% 13.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.99% 11.57%
CYH Community Health Systems, Inc. Buy 6.36% 21.88%
VRDN Viridian Therapeutics, Inc. Buy 6.11% 11.2%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.43% 21.63%
OPK OPKO Health, Inc. Buy 5.78% 8.33%
ALT Altimmune, Inc. Buy 6.19% 5.61%
BHVN Biohaven Ltd. Buy 6.25% 6.27%
PDSB PDS Biotechnology Corporation Buy 5.62% 20.03%
WST West Pharmaceutical Services, Inc. Buy 5.84% -3.96%
AVNS Avanos Medical, Inc. Buy 6.01% -1.18%
TDOC Teladoc Health, Inc. Buy 6.01% -1.17%
SGRY Surgery Partners, Inc. Buy 6.12% 0.74%
RGNX REGENXBIO Inc. Buy 5.54% 1.26%
ANGO AngioDynamics, Inc. Buy 5.99% -3.26%
CUTR Cutera, Inc. Buy 5.52% 4.05%
FGEN FibroGen, Inc. Sell -3.82% -2.91%
The percentage of cash held in the portfolio is: 2.36%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Buy All -10.22%
Assets Rebalanced
Asset Action Weight
RGNX Sell -0.61%
CUTR Sell -0.8%
PDSB Sell -0.78%
ACAD Sell -0.95%
ANGO Sell -0.61%
RARE Sell -0.72%
2024-07-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.46% 11.9%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.24% 34.37%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.86% 13.27%
CYH Community Health Systems, Inc. Buy 6.24% 18.75%
VRDN Viridian Therapeutics, Inc. Buy 5.83% 5.15%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.24% 17.23%
BHVN Biohaven Ltd. Buy 6.24% 5.28%
ALT Altimmune, Inc. Buy 6.24% 5.61%
OPK OPKO Health, Inc. Buy 5.62% 4.55%
PDSB PDS Biotechnology Corporation Buy 6.24% 16.19%
SGRY Surgery Partners, Inc. Buy 6.44% 5.17%
RGNX REGENXBIO Inc. Buy 6.16% 0.47%
TDOC Teladoc Health, Inc. Buy 6.14% 0.21%
AVNS Avanos Medical, Inc. Buy 6.1% -0.47%
CUTR Cutera, Inc. Buy 6.09% -0.68%
ANGO AngioDynamics, Inc. Buy 6.74% -2.12%
WST West Pharmaceutical Services, Inc. Buy 5.94% -3.1%
FGEN FibroGen, Inc. Sell -3.78% -0.97%
APLS Apellis Pharmaceuticals, Inc. Sell -4.37% -8.93%
The percentage of cash held in the portfolio is: 2.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Buy All -25%
CDNA Buy All -10.41%
Assets Rebalanced
Asset Action Weight
VRDN Sell -0.97%
OPK Sell -1.34%
BHVN Sell -0.77%
ALT Sell -0.79%
RYTM Sell -1.33%
PDSB Sell -1.49%
EGRX Sell -1.51%
CYH Sell -1.55%
ANGO Buy 0.25%
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.52% 11.15%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.89% 34.6%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.78% 10.14%
CYH Community Health Systems, Inc. Buy 7.73% 15.94%
VRDN Viridian Therapeutics, Inc. Buy 6.44% -1.97%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.17% 9.21%
PDSB PDS Biotechnology Corporation Buy 7.46% 10.23%
BHVN Biohaven Ltd. Buy 7.1% 4.89%
ALT Altimmune, Inc. Buy 6.95% 2.67%
OPK OPKO Health, Inc. Buy 7.02% 3.79%
WST West Pharmaceutical Services, Inc. Buy 6.23% 0%
ANGO AngioDynamics, Inc. Buy 6.23% 0%
TDOC Teladoc Health, Inc. Buy 6.23% 0%
SGRY Surgery Partners, Inc. Buy 6.23% 0%
AVNS Avanos Medical, Inc. Buy 6.23% 0%
CUTR Cutera, Inc. Buy 6.23% 0%
RGNX REGENXBIO Inc. Buy 6.23% 0%
FGEN FibroGen, Inc. Sell -3.61% 4.95%
SGMO Sangamo Therapeutics, Inc. Sell -4.83% -22.22%
APLS Apellis Pharmaceuticals, Inc. Sell -4.37% -7.16%
CDNA CareDx, Inc Sell -3.83% -9.44%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • WST
  • ANGO
  • TDOC
  • SGRY
  • AVNS
  • CUTR
  • RGNX
Assets Removed
Asset Action Perf %
PAHC Buy All -6.77%
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.44% 7.75%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.06% 34.82%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.69% 6.55%
CYH Community Health Systems, Inc. Buy 7.09% 4.37%
VRDN Viridian Therapeutics, Inc. Buy 6.21% -7.12%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.96% 4.01%
PDSB PDS Biotechnology Corporation Buy 6.9% 0%
BHVN Biohaven Ltd. Buy 6.9% 0%
ALT Altimmune, Inc. Buy 6.9% 0%
OPK OPKO Health, Inc. Buy 6.9% 0%
FGEN FibroGen, Inc. Sell -3.39% 12.33%
SGMO Sangamo Therapeutics, Inc. Sell -4.47% -11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -4.29% -3.17%
PAHC Phibro Animal Health Corporation Sell -3.57% 0%
CDNA CareDx, Inc Sell -3.57% 0%
The percentage of cash held in the portfolio is: 50.27%
New Assets Added
  • PAHC
  • CDNA
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.39% 7.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.03% 35.49%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.59% 6.02%
CYH Community Health Systems, Inc. Buy 6.99% 3.75%
VRDN Viridian Therapeutics, Inc. Buy 6.2% -6.59%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.99% 5.32%
FGEN FibroGen, Inc. Sell -3.13% 18.54%
SGMO Sangamo Therapeutics, Inc. Sell -3.88% 2.78%
APLS Apellis Pharmaceuticals, Inc. Sell -4.26% -3.44%
The percentage of cash held in the portfolio is: 70.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVRO Sell All -11.61%
Assets Rebalanced
None
2024-07-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.07% 2.77%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.93% 34.15%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.46% 4.12%
CYH Community Health Systems, Inc. Buy 6.8% 1.25%
NVRO Nevro Corp. Buy 6.43% -2.79%
VRDN Viridian Therapeutics, Inc. Buy 6.17% -6.81%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.79% 2.55%
FGEN FibroGen, Inc. Sell -3.01% 21.46%
SGMO Sangamo Therapeutics, Inc. Sell -3.54% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -4.19% -1.98%
The percentage of cash held in the portfolio is: 64.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
VERU Sell All -3.41%
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.82% -1.83%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.28% 22.77%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.28% 0.9%
CYH Community Health Systems, Inc. Buy 7.09% 5.31%
NVRO Nevro Corp. Buy 6.46% -2.67%
VRDN Viridian Therapeutics, Inc. Buy 6.15% -7.27%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.35% -4.36%
VERU Veru Inc. Buy 6.86% 3.41%
FGEN FibroGen, Inc. Sell -2.58% 32.91%
SGMO Sangamo Therapeutics, Inc. Sell -3.55% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -4.02% 2.42%
The percentage of cash held in the portfolio is: 57.86%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.88% -0.25%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.88% 16.74%
STAA STAAR Surgical Company Buy 6.51% 5.2%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.36% 2.79%
CYH Community Health Systems, Inc. Buy 7.18% 7.19%
NVRO Nevro Corp. Buy 6.4% -3.02%
VRDN Viridian Therapeutics, Inc. Buy 6.08% -7.95%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.55% -0.77%
VERU Veru Inc. Buy 7.13% 7.95%
FGEN FibroGen, Inc. Sell -2.76% 27.86%
SGMO Sangamo Therapeutics, Inc. Sell -3.53% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -3.96% 3.61%
The percentage of cash held in the portfolio is: 51.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
MNKD Sell All -7.37%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.74% 1.01%
MNKD MannKind Corporation Buy 5.33% -6.26%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.02% 23.44%
STAA STAAR Surgical Company Buy 6.69% 12.05%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.16% 3.19%
CYH Community Health Systems, Inc. Buy 6.7% 3.75%
ARDX Ardelyx, Inc. Buy 6.95% 2.16%
CHRS Coherus BioSciences, Inc. Buy 6.33% -6.94%
NVRO Nevro Corp. Buy 6.37% 0%
VRDN Viridian Therapeutics, Inc. Buy 6.37% 0%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.37% 0%
VERU Veru Inc. Buy 6.37% 0%
FGEN FibroGen, Inc. Sell -2.75% 25.24%
SGMO Sangamo Therapeutics, Inc. Sell -3.51% 8.33%
APLS Apellis Pharmaceuticals, Inc. Sell -3.96% 0%
The percentage of cash held in the portfolio is: 33.83%
New Assets Added
  • APLS
  • NVRO
  • VRDN
  • RYTM
  • VERU
Assets Removed
Asset Action Perf %
NVRO Buy All -8.17%
MODV Buy All -8.11%
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.81% 2.33%
MNKD MannKind Corporation Buy 5.46% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.09% 25%
STAA STAAR Surgical Company Buy 6.7% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.15% 3.14%
CYH Community Health Systems, Inc. Buy 6.77% 5%
ARDX Ardelyx, Inc. Buy 6.79% 0%
CHRS Coherus BioSciences, Inc. Buy 6.79% 0%
NVRO Nevro Corp. Sell -3.89% -5.78%
MODV ModivCare Inc. Sell -3.82% -4.83%
FGEN FibroGen, Inc. Sell -3.18% 13.4%
SGMO Sangamo Therapeutics, Inc. Sell -3.82% 0%
The percentage of cash held in the portfolio is: 63.15%
New Assets Added
  • SGMO
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.93% 3.09%
MNKD MannKind Corporation Buy 5.6% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.44% 12.05%
STAA STAAR Surgical Company Buy 6.67% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.28% 3.94%
CYH Community Health Systems, Inc. Buy 6.54% 0%
NVRO Nevro Corp. Sell -3.92% -5.03%
MODV ModivCare Inc. Sell -3.73% -0.84%
FGEN FibroGen, Inc. Sell -3.73% 0%
The percentage of cash held in the portfolio is: 73.9%
New Assets Added
  • FGEN
  • CYH
Assets Removed
Asset Action Perf %
AVXL Buy All -12.3%
Assets Rebalanced
None
2024-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.64% -2.39%
MNKD MannKind Corporation Buy 5.52% -4.42%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.35% 9.82%
STAA STAAR Surgical Company Buy 6.52% 7.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.17% 1.71%
NVRO Nevro Corp. Sell -4.01% -7.16%
MODV ModivCare Inc. Sell -3.71% 0%
AVXL Anavex Life Sciences Corp. Sell -3.71% 0%
The percentage of cash held in the portfolio is: 81.24%
New Assets Added
  • MODV
  • AVXL
Assets Removed
Asset Action Perf %
FGEN Sell All -12.08%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.68% -1.76%
MNKD MannKind Corporation Buy 5.58% -3.5%
FGEN FibroGen, Inc. Buy 5.64% -2.5%
EGRX Eagle Pharmaceuticals, Inc. Buy 5.88% 1.56%
STAA STAAR Surgical Company Buy 6.07% 0%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.07% 0%
NVRO Nevro Corp. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 68.82%
New Assets Added
  • NVRO
  • STAA
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.76% 0%
MNKD MannKind Corporation Buy 5.76% 0%
FGEN FibroGen, Inc. Buy 5.76% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 76.94%
New Assets Added
  • ACAD
  • MNKD
  • FGEN
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-06-17 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
RCM Sell All 0.32%
Assets Rebalanced
None
2024-06-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -2.15% -1.44%
The percentage of cash held in the portfolio is: 102.15%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGRY Buy All 6.39%
Assets Rebalanced
None
2024-06-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -2.24% 2.64%
SGRY Surgery Partners, Inc. Sell -1.71% 4.25%
The percentage of cash held in the portfolio is: 103.95%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Buy All 12.51%
Assets Rebalanced
None
2024-06-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -2.24% 2.24%
VRDN Viridian Therapeutics, Inc. Sell -3.46% 12.08%
SGRY Surgery Partners, Inc. Sell -1.74% 2.48%
The percentage of cash held in the portfolio is: 107.43%
New Assets Added
None
Assets Removed
Asset Action Perf %
ILMN Buy All -1.68%
Assets Rebalanced
None
2024-06-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -2.22% 2.16%
ILMN Illumina, Inc. Sell -3.77% 9.54%
VRDN Viridian Therapeutics, Inc. Sell -3.26% 16.61%
SGRY Surgery Partners, Inc. Sell -1.72% 2.97%
The percentage of cash held in the portfolio is: 110.97%
New Assets Added
None
Assets Removed
Asset Action Perf %
AORT Sell All 11.42%
OMCL Sell All 1.76%
Assets Rebalanced
None
2024-06-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 7.61% 12.42%
OMCL Omnicell, Inc. Buy 8.65% 4.91%
RCM R1 RCM Inc. Buy -2.22% 2.32%
ILMN Illumina, Inc. Sell -3.82% 8.38%
VRDN Viridian Therapeutics, Inc. Sell -3.36% 13.73%
SGRY Surgery Partners, Inc. Sell -1.76% 0.38%
The percentage of cash held in the portfolio is: 94.9%
New Assets Added
None
Assets Removed
Asset Action Perf %
ICUI Buy All -6.33%
Assets Rebalanced
None
2024-06-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 7.6% 12.76%
OMCL Omnicell, Inc. Buy 8.89% 8.16%
RCM R1 RCM Inc. Buy -2.22% 2.88%
ILMN Illumina, Inc. Sell -3.84% 7.57%
VRDN Viridian Therapeutics, Inc. Sell -3.34% 14.09%
SGRY Surgery Partners, Inc. Sell -1.83% -3.8%
ICUI ICU Medical, Inc. Sell -4.81% -2.26%
The percentage of cash held in the portfolio is: 99.55%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Sell All 17.73%
ALT Sell All 4.45%
KIDS Sell All -0.72%
GKOS Sell All 7.32%
Assets Rebalanced
None
2024-05-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 8.75% 14.89%
ALT Altimmune, Inc. Buy 7.78% -4.73%
KIDS OrthoPediatrics Corp. Buy 8.21% 2.07%
GKOS Glaukos Corporation Buy 8.36% 5.06%
AORT Artivion, Inc. Buy 7.71% 13.47%
OMCL Omnicell, Inc. Buy 8.74% 5.58%
RCM R1 RCM Inc. Buy -2.24% 3.04%
ILMN Illumina, Inc. Sell -3.77% 9.8%
VRDN Viridian Therapeutics, Inc. Sell -3.37% 13.87%
SGRY Surgery Partners, Inc. Sell -1.78% -0.6%
ICUI ICU Medical, Inc. Sell -4.61% 2.74%
The percentage of cash held in the portfolio is: 66.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Buy All -12.87%
ALGN Buy All 17.08%
SGMO Sell All 5.56%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings